companydata.dkBIOMOTION PHARMA ApS: Financial statements 2018
CVR: 12928203
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 5,000 and a net result of DKK 5,000 compared with DKK 0 the year before. Equity amounted to DKK 4,001. The solvency ratio was 76.2%.
- Gross Profit
- 5,000 kr.
- Profit/Loss
- 5,000 kr.
- Equity
- 4,001 kr.
- Total Assets
- 5,251 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 5 t. | 5 t. | 4 t. | - |
| 2017 | - | - | 0 | -999 | - |
| 2016 | - | 0 | 0 | -999 | - |
| 2015 | - | 3 t. | -2 t. | -999 | - |
| 2014 | - | -999 | -999 | 983 | - |
Keep an eye on BIOMOTION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
BIOMOTION PHARMA ApS has published its annual report for 2017. The net result was DKK 0.
About BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Henrik Selchau Poulsen. The company is owned by Michael Rasmussen. In 2024, the company reported a gross profit of DKK -5,313 and a net result of DKK -6,460 compared with DKK -1,430 the year before. Equity amounted to DKK 3,310.